November 18, 2026
Health news, explained with evidence
LIVE

Study Maps Peripheral Immune Changes in End-Stage Lung Disease Patients Waiting for Transplants

🏃 Fitness 2 min read 👁 2

Researchers at the Medical University of Vienna investigated the peripheral immune landscape of 134 lung transplant candidates to understand how advanced fibrotic and obstructive diseases alter blood immune cells.

🏃Fitness

Key points

  • Analyzed whole blood from 134 lung transplant candidates and 53 healthy controls.
  • Identified shared immune features like leukocytosis and CD8⁺ T cell expansion in fibrosis and obstruction.
  • Found that pre-transplant immune states did not predict overall or graft-free survival.

A team of researchers led by scientists at the Medical University of Vienna has published a study mapping the peripheral immune profiles of patients with end-stage lung disease on the transplant waiting list. Published in Sci Rep, the investigation analyzed whole blood samples from 134 lung transplant candidates and 53 healthy controls using flow cytometry and unsupervised clustering. The findings suggest that both advanced fibrotic and obstructive lung conditions share a convergent reprogramming of peripheral immunity, marked by overall leukocytosis and lymphoid contraction.

Specifically, the study observed that total leukocyte counts were significantly elevated in both patient groups, with higher levels seen in fibrosis compared to obstruction. Furthermore, certain cell populations such as CD8⁺ T cells and specific regulatory T cells were expanded across both conditions. However, the researchers noted that fibrosis featured a more pronounced CD4⁺ contraction along with selective enrichment of Helios⁺ regulatory T cells. Out of the total cohort, 114 candidates subsequently underwent transplantation, allowing the team to test whether the baseline immune state predicted overall survival or chronic lung allograft dysfunction-free survival. Statistical analysis indicated that these pre-transplant peripheral immune characteristics did not predict post-transplant survival outcomes.

Readers should note that this observational study has inherent limitations regarding sample size and the cross-sectional nature of pre-transplant profiling. Because the findings are early stage, they do not establish predictive markers for post-transplant success or provide personal medical guidance. What to know: Advanced lung diseases involve systemic immune shifts, but these blood markers do not currently forecast transplant survival. Patients facing lung conditions should always consult a qualified physician for personalized care decisions.

Source Nature Health Sciences — nature.com/articles/s41598-026-80388-2 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.